These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37226807)

  • 1. A review of HTA guidelines on societal and novel value elements.
    Breslau RM; Cohen JT; Diaz J; Malcolm B; Neumann PJ
    Int J Technol Assess Health Care; 2023 May; 39(1):e31. PubMed ID: 37226807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How is the Societal Perspective Defined in Health Technology Assessment? Guidelines from Around the Globe.
    Avşar TS; Yang X; Lorgelly P
    Pharmacoeconomics; 2023 Feb; 41(2):123-138. PubMed ID: 36471131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic Evaluation of Medically Assisted Reproduction: A Methodological Systematic Review.
    Van Muylder A; D'Hooghe T; Luyten J
    Med Decis Making; 2023; 43(7-8):973-991. PubMed ID: 37621143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review of economic evaluations for
    Farris M; Goodall S; De Abreu Lourenco R
    Int J Technol Assess Health Care; 2023 Jun; 39(1):e38. PubMed ID: 37313789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are Key Principles for improved health technology assessment supported and used by health technology assessment organizations?
    ; Neumann PJ; Drummond MF; Jönsson B; Luce BR; Schwartz JS; Siebert U; Sullivan SD
    Int J Technol Assess Health Care; 2010 Jan; 26(1):71-8. PubMed ID: 20059783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Equity in national healthcare economic evaluation guidelines: Essential or extraneous?
    Saygın Avşar T; Yang X; Lorgelly P
    Soc Sci Med; 2024 Sep; 357():117220. PubMed ID: 39153234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health technology assessment of medical devices: What is different? An overview of three European projects.
    Schnell-Inderst P; Mayer J; Lauterberg J; Hunger T; Arvandi M; Conrads-Frank A; Nachtnebel A; Wild C; Siebert U
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):309-18. PubMed ID: 26354131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Models and applications for measuring the impact of health research: update of a systematic review for the Health Technology Assessment programme.
    Raftery J; Hanney S; Greenhalgh T; Glover M; Blatch-Jones A
    Health Technol Assess; 2016 Oct; 20(76):1-254. PubMed ID: 27767013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternatives to the quality-adjusted life year: How well do they address common criticisms?
    Rand LZ; Melendez-Torres GJ; Kesselheim AS
    Health Serv Res; 2023 Apr; 58(2):433-444. PubMed ID: 36537647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Key principles for the improved conduct of health technology assessments for resource allocation decisions.
    Drummond MF; Schwartz JS; Jönsson B; Luce BR; Neumann PJ; Siebert U; Sullivan SD
    Int J Technol Assess Health Care; 2008; 24(3):244-58; discussion 362-8. PubMed ID: 18601792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The economic value of vaccinations: a systematic review of Italian economic evaluations and HTA reports].
    Di Nardo F; Boccalini S; Calabrò GE; Marcellusi A; Ruggeri M; Bonanni P; Vitali R; Capannini E; Mennini FS; Cicchetti A; Panatto D; Gasparini R; Ricciardi W; De Waure C
    Ig Sanita Pubbl; 2017; 73(5):453-471. PubMed ID: 29433132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot study on the use of decision theory and value of information analysis as part of the NHS Health Technology Assessment programme.
    Claxton K; Ginnelly L; Sculpher M; Philips Z; Palmer S
    Health Technol Assess; 2004 Jul; 8(31):1-103, iii. PubMed ID: 15248937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reconstructing the value puzzle in health technology assessment: a pragmatic review to determine which modelling methods can account for additional value elements.
    Muir JM; Radhakrishnan A; Freitag A; Ozer Stillman I; Sarri G
    Front Pharmacol; 2023; 14():1197259. PubMed ID: 37521458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
    Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
    Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncertainty in Long-Term Relative Effectiveness of Medicines in Health Technology Assessment.
    Versteeg JW; Vreman R; Mantel-Teeuwisse A; Goettsch W
    Value Health; 2024 Oct; 27(10):1358-1366. PubMed ID: 38971220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reported Challenges in Health Technology Assessment of Complex Health Technologies.
    Hogervorst MA; Vreman RA; Mantel-Teeuwisse AK; Goettsch WG
    Value Health; 2022 Jun; 25(6):992-1001. PubMed ID: 35667787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Which Criteria are Considered and How are They Evaluated in Health Technology Assessments? A Review of Methodological Guidelines Used in Western and Asian Countries.
    Wang Y; Qiu T; Zhou J; Francois C; Toumi M
    Appl Health Econ Health Policy; 2021 May; 19(3):281-304. PubMed ID: 33426626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Algorithms and heuristics of health technology assessments: A retrospective analysis of factors associated with HTA outcomes for new drugs across seven OECD countries.
    Kanavos P; Visintin E; Gentilini A
    Soc Sci Med; 2023 Aug; 331():116045. PubMed ID: 37450991
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.